Blood marker study aims to predict preterm birth risk

NCT ID NCT01977079

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a blood marker called procalcitonin can help predict which pregnant women hospitalized for threatened premature labor will actually deliver early. About 131 women participated, and researchers compared procalcitonin levels between those who gave birth before 37 weeks and those who did not. The goal was to improve prediction of preterm birth, but the study was terminated early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre hospitalier départemental Vendée

    La Roche-sur-Yon, 85925, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.